The sales revenue of the BioTechUSA company group increased by 40 percent last year
The BioTechUSA company group closed the year 2022 with a record financial result, its sales revenue increased by 41 percent and reached HUF 80.4 billion, its earnings before interest, taxes and depreciation (EBITDA) increased from HUF 9.2 billion to HUF 11.5 billion.
The Hungarian family-owned group of companies expanded its portfolio with 300 new products, opened 17 new stores and launched the largest investment in its history in 2022, which will continue this year – explained Bálint Lévai, CEO and co-owner of BioTechUSA Kft., at the press conference presenting the company’s annual results.
About 80 percent of the total sales revenue of one of the largest food supplement and specialty food manufacturing and distribution groups in Europe last year came from exports, and the international store network produced a 216 percent increase in turnover.
Related news
BioTechUSA group makes the largest investment in its history of 9 billion forints
The purely Hungarian-owned BioTechUSA group is implementing the largest investment…
Read more >Randstad: a magyarországi vállalatok 50 százaléka nettó árbevételének növekedésére számít az idén
50 percent of the Hungarian companies surveyed expect their net…
Read more >BioTechUSA starts the year with the message “Franco is sporty. Be a Franco too!” and encourages lifestyle changes
As one of Europe’s largest manufacturers and distributors of dietary…
Read more >Related news
Margin is very much not profit
The government announced that it would introduce a margin cap…
Read more >Margin freeze in Hungary: Who is affected and is government intervention really justified?
The Hungarian government will introduce a margin restriction on certain…
Read more >China’s retail sales skyrocket in the first two months of the year
China’s industrial output grew 5.9 percent year-on-year in the first…
Read more >